山东大学耳鼻喉眼学报 ›› 2018, Vol. 32 ›› Issue (6): 30-37.doi: 10.6040/j.issn.1673-3770.0.2018.021

• 论著 • 上一篇    下一篇

MicroRNA-24对人喉鳞癌细胞生物学行为的影响

许莉1,王志颐1,陈伟1,薛飞1,张勇1,程友1,季俊峰1,崔鹏程2,江满杰1   

  1. 1.中国人民解放军东部战区总医院耳鼻咽喉科, 江苏 南京 210002;
    2.空军军医大学唐都医院耳鼻咽喉头颈外科, 陕西 西安 710038
  • 发布日期:2018-11-29
  • 通讯作者: 江满杰. E-mail:jiangmjdoc@163.com
  • 作者简介:许莉. E-mail:xulinjzy@126.com
  • 基金资助:
    江苏省青年医学重点人才项目(QNRC2016917)

Effect of MicroRNA-24 on the proliferation, migration, invasion, and apoptosis of LSCC cells

XU Li1, WANG Zhiyi1, CHEN Wei1, XUE Fei1, ZHANG Yong1, CHENG You1, JI Junfeng1, CUI Pengcheng2, JIANG Manjie1   

  1. Department of Otolaryngology Head and Neck Surgery, Tangdu Hospital, Air Force Military Medical University, Xian 710038, Shaanxi, China
  • Published:2018-11-29

摘要: 目的 探讨MicroRNA-24(miR-24)对喉鳞状细胞癌(LSCC)Hep-2、AMC-HN-8细胞增殖、侵袭及凋亡等生物学行为的影响。 方法 应用LipofectamineTM 2000转染上调Hep-2、AMC-HN-8细胞中miR-24的表达,通过荧光定量PCR验证转染效率;然后分别采用MTT法、克隆形成实验、细胞划痕实验、Transwell侵袭实验流式细胞分析技术分析外源上调miR-24后Hep-2、AMC-HN-8细胞增殖、迁移、侵袭及凋亡的影响。 结果 miR-24质粒稳定转染Hep-2、AMC-HN-8细胞后miR-24表达明显上调。与转染miR-NC组和空白对照组相比,转染miR-24能明显降低Hep-2细胞的增殖、迁移和侵袭能力;同时,转染miR-24能明显增加Hep-2、AMC-HN-8细胞的凋亡能力。 结论 miR-24异常表达与LSCC Hep-2、AMC-HN-8细胞的生物学行为密切相关,可能发挥抑癌作用。

关键词: 喉鳞癌, MicroRNA-24, 增殖, 迁移, 侵袭, 凋亡

Abstract: Objective The effect of miR-24 on the proliferation, migration, invasion, and apoptosis of LSCC cells was examined. Methods After constructing Hep-2 and AMC-HN-8 cells to overexpress miR-24 by cell transfection, the proliferation of Hep-2 and AMC-HN-8 cells was detected by MTT assay and a cloning assay. A scratch test and Transwell assay were conducted to detect cell migration and invasion abilities, and the effect on apoptosis was analyzed by using flow cytometry analysis. Results After cell transfection, qRT-PCR confirmed upregulation of miR-24 in Hep-2/miR-24 and AMC-HN-8/miR-24 cells. MTT and colony formation assays showed that upregulation of miR-24 significantly reduced the proliferation of LSCC cells. Additionally, the capacity for colony formation in Hep-2/miR-24 and AMC-HN-8/miR-24 cells was significantly reduced compared to that of control cells. The scratch test and Transwell assay showed that the migration and invasion ability of miR-24 were significantly reduced. Flow cytometry showed that overexpression of miR-24 significantly enhanced apoptosis in LSCC cells. These results suggest that miR-24 inhibits the proliferation, invasion, and metastasis and increases the apoptosis of LSCC cells. Conclusion Abnormal expression of miR-24 is closely related to properties of LSCC cells. miR-24 inhibits the proliferation and migration and enhances the apoptosis of LSCC cells.

Key words: Laryngeal squamous carcinoma, MicroRNA-24, Inhibition, Proliferation, Invasion, Apoptosis

中图分类号: 

  • R739.65
[1] Genden EM, Ferlito A, Silver CE, et al. Evolution of the management of laryngeal cancer[J]. Oral Oncol, 2007, 43(5):431-439.
[2] Yu YH, Kuo HK, Chang KW. The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review[J]. PLoS One, 2008, 3(9):e3215.
[3] Li L, Zhang ZM, Liu Y, et al. DNA microarrays-based microRNA expression profiles derived from formalin-fixed paraffin-embedded tissue blocks of squammous cell carcinoma of larynx[J]. Zhonghua Bing Li Xue Za Zhi, 2010, 39(6):391-395.
[4] Wery M, Kwapisz M, Morillon A. Noncoding RNAs in gene regulation[J]. Wiley Interdiscip Rev Syst Biol Med, 2011, 3(6):728-738.
[5] Le HB, Zhu WY, Chen DD, et al. Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients[J]. Med Oncol, 2012, 29(5):3190-3197.
[6] Chen L, Luo L, Chen W, et al. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53[J]. Biomed Pharmacother, 2016, 84:1113-1118.
[7] Zhao J, Hu C, Chi J, et al. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7[J]. Oncol Rep, 2016, 36(2):1143-1149.
[8] Nguyen T, Rich A, Dahl R. MiR-24 promotes the survival of hematopoietic cells[J]. PLoS One, 2013, 8(1):e55406.
[9] Liu Z, Liu Z, Zhang Y, et al. miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway[J]. Biochem Biophys Res Commun, 2017, 486(2):211-217.
[10] Yu G, Jia Z, Dou Z. miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD[J]. Oncol Rep, 2017, 37(2):1123-1131.
[11] Gong JP, Yang L, Tang JW, et al. Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9[J]. Oncol Lett, 2016, 12(5):3905-3911.
[12] Liu R, Zhang H, Wang X, et al. The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma[J]. Oncotarget, 2015, 6(41):43831-43842.
[13] Organista-Nava J, Gomez-Gomez Y, Illades-Aguiar B, et al. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia[J]. Oncol Rep, 2015, 33(4):1639-1649.
[14] Li YQ, Lu JH, Bao XM, et al. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1[J]. J Exp Clin Cancer Res, 2015, 34:130.
[15] Kang M, Xiao J, Wang J, et al. MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1[J]. Cancer Med, 2016, 5(6):1163-1173.
[16] Lynch SM, Mckenna MM, Walsh CP, et al. miR-24 regulates CDKN1B/p27 expression in prostate cancer[J]. Prostate, 2016, 76(7):637-648.
[17] Ma Y, She XG, Ming YZ, et al. miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7[J]. Tumour Biol, 2014, 35(11):10731-10736.
[18] Lin SC, Liu CJ, Lin JA, et al. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis[J]. Oral Oncol, 2010, 46(3):204-208.
[1] 吴敏,李正阳,孟杰,叶惠平. 程序性细胞死亡的分子机制和其在鼻咽癌中的作用[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 152-157.
[2] 辛梦,纪芳,代春华,张靖,刘澍. 医用透明质酸钠与平衡盐溶液在微创玻璃体手术中对眼表保护的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 58-65.
[3] 吴翠萍,朱一丹,李春燕,殷善开. 胆红素对神经干细胞活性和增殖的影响研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 1-6.
[4] 袁玥,庞文会,陈敏,付圣尧,于龙刚,孙钰博,李玲玲. 毛霉菌性鼻窦炎25例临床特征分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 102-107.
[5] 付艺璇,王涛,曹静,李光达,郑凌方,许莞菁,赵爽. 羟基红花黄色素A对大鼠视网膜光损伤的保护作用[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 128-134.
[6] 颜繁诚,蒋现,柴一杰,王昊森,孟照洋,汪晓磊,王艳玲,冯雪. miR-30-5p通过下调FOXG1表达抑制视网膜母细胞瘤细胞增殖[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 63-69.
[7] 刘勇,袁存立,曹慧,郑成彩,晁方, 许风雷. CHD1L通过EMT促进喉鳞状细胞癌细胞的增殖、侵袭和转移[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 32-39.
[8] 王俊鑫,孙岩. miRNA-29b参与上皮间质转化相关信号通路调控的研究进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 132-137.
[9] 刘志高,王淑雅,韩旭光,王玉,李志伟,马爱华,赵博军. 增殖性糖尿病视网膜病变术前玻璃体腔应用阿柏西普的时机及其疗效观察[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 99-103.
[10] 朱正茹,张小兵. 高迁移率族蛋白B1与变应性鼻炎的相关性[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 123-128.
[11] 裴雪艳,王琰. 侵袭性伪足和MMP-14在肿瘤发病机制中的研究进展[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 129-134.
[12] 青晓艳,徐义全,李超. 甲状腺未分化癌的分子机制研究[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 26-31.
[13] 许玲, 孙岩. 三叶因子家族在中耳呼吸型黏膜上皮的研究进展[J]. 山东大学耳鼻喉眼学报, 2020, 34(1): 93-98.
[14] 李林,张衡,冼宇飞,盛晓丽. 长链非编码RNA在鼻咽癌组织中表达及其生物学功能研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 69-72.
[15] 潘晓菲,王军,肖洋,马丽晶. LncRNA CTB-147C22.8对复发性呼吸道乳头状瘤细胞侵袭的影响[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 66-70.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!